Validation of a Commercial ELISA Kit for Non-Invasive Measurement of Biologically Relevant Changes in Equine Cortisol Concentrations

dc.contributor.authorShare, Elizabeth R.en
dc.contributor.authorMastellar, Sara L.en
dc.contributor.authorSuagee-Bedore, Jessica K.en
dc.contributor.authorEastridge, Maurice L.en
dc.date.accessioned2024-10-15T13:24:26Zen
dc.date.available2024-10-15T13:24:26Zen
dc.date.issued2024-10-01en
dc.date.updated2024-10-15T12:52:34Zen
dc.description.abstractThe measurement of fecal cortisol/corticosterone metabolites (FCMs) is often used to quantify the stress response. The sampling method is relatively non-invasive, reduces concern for elevation of cortisol from the sampling method, and has been shown to measure cortisol more consistently without the daily diurnal rhythm observed in blood. Commercial ELISA (enzyme-linked immunoassay) kits offer benefits over previously validated immunoassay methods but lack validation. The objective of this study was to evaluate a commercial ELISA kit (Arbor Assays<sup>TM</sup> DetectX<sup>&reg;</sup> Cortisol ELISA kit, K003-H1, Ann Arbor, MI, USA) and provide analytical and biologic validation of equine fecal and plasma samples. Horses (4 male, 4 female, mean &plusmn; SD: 4 &plusmn; 5 yr) were transported for 15 min with limited physical and visual contact via a livestock trailer. Blood and fecal samples were collected pre- and post-transportation. Parallelism, accuracy, and precision tests were used to analytically validate this kit. Data were analyzed using PROC MIXED in SAS 9.4. Plasma cortisol concentrations increased in response to trailering (254.5 &plusmn; 26.4 nmol/L, 0 min post-transportation) compared to pre-transportation (142.8 &plusmn; 26.4 nmol/L). FCM concentrations increased 24 h post-trailering (10.8 &plusmn; 1.7 ng/g) when compared to pre-transportation (7.4 &plusmn; 1.7 ng/g). These data support that changes in FCMs can be observed 24 h post-stressor. In conclusion, the Arbor Assays<sup>TM</sup> DetectX<sup>&reg;</sup> Cortisol ELISA kit is a reliable, economic option for the measurement of biologically relevant changes in cortisol in equine plasma and FCMs.en
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationShare, E.R.; Mastellar, S.L.; Suagee-Bedore, J.K.; Eastridge, M.L. Validation of a Commercial ELISA Kit for Non-Invasive Measurement of Biologically Relevant Changes in Equine Cortisol Concentrations. Animals 2024, 14, 2831.en
dc.identifier.doihttps://doi.org/10.3390/ani14192831en
dc.identifier.urihttps://hdl.handle.net/10919/121343en
dc.language.isoenen
dc.publisherMDPIen
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.subjectcortisolen
dc.subjectELISAen
dc.subjectequineen
dc.subjecthorseen
dc.subjectstressen
dc.subjectfecalen
dc.titleValidation of a Commercial ELISA Kit for Non-Invasive Measurement of Biologically Relevant Changes in Equine Cortisol Concentrationsen
dc.title.serialAnimalsen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
animals-14-02831.pdf
Size:
1.7 MB
Format:
Adobe Portable Document Format
Description:
Published version
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.5 KB
Format:
Item-specific license agreed upon to submission
Description: